Prasita 10mg Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Prasugrel (10mg)
Overview Prasita 10mg Tablet
Cardiogard 10mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the creation of dangerous blood clots, promoting healthy blood flow. This reduces the risk of subsequent heart attacks or strokes in individuals with cardiac conditions. Cardiogard 10mg is indicated for patients recovering from a recent heart attack or experiencing severe angina (chest pain) and who've received coronary stenting. It helps prevent further cardiovascular events, including recurrent heart attacks, strokes, and stent thrombosis. This medication is often prescribed alongside aspirin, another antiplatelet drug. It can be administered with or without food, but consistent daily dosing is crucial for efficacy. Continued use is vital even during periods of well-being; discontinuation raises the risk of further cardiac incidents. The most frequent adverse effect is bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or abnormally heavy menstrual bleeding. Wound healing may be prolonged. While generally mild and self-limiting, persistent or concerning bleeding necessitates immediate medical attention. This medication is contraindicated in individuals with active internal bleeding (e.g., ulcers, intracranial hemorrhage) or severe hepatic impairment. Prior to commencing treatment, disclose any history of bleeding disorders, recent significant injuries, or upcoming surgeries to your physician. Temporary cessation may be necessary before scheduled procedures.
Uses of Prasita 10mg Tablet
Cardiovascular event prevention
Major Benefits of Prasita 10mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Prasita 10mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Prasita 10mg Tablet:
- Bleeding
How to use Prasita 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Prasita 10mg Tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency in timing is recommended.
How Prasita 10mg Tablet works:
CardioGuard 10mg tablets inhibit platelet aggregation, a key process in blood clot formation. This antiplatelet action reduces the risk of recurrent cardiovascular events such as stroke or myocardial infarction.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse interactions between Prasita 10mg Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Data on Prasita 10mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Prasita 10mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Prasita 10mg Tablet.
KidneySAFE IF PRESCRIBED
Prasita 10mg tablets appear safe for use in individuals with kidney conditions. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Prasita 10mg Tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Data regarding Prasita 10mg Tablet use in such patients is limited. Dosage alteration isn't advised for those with mild or moderate liver dysfunction.
What if you forget to take Prasita 10mg Tablet :
Should you forget a Prasita 10mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Prasita 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Piperazine-based compound |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |



